Wall Street drifts around its records as its relentless rally takes a breath
The S&P 500 dipped 0.1%. The Dow Jones Industrial Average was down 103 points, or 0.2%, as of
It’s only a modest pullback when compared with the surge that stocks have enjoyed hitting a bottom in April. Driving the market have been hopes that President Donald Trump’s tariffs won’t derail global trade and that the
The Fed made its first cut of the year to rates last week, and officials indicated they could deliver more through the end of this year and into next.
“Every time the market seems to be running out of momentum, it fools most of us by pushing to higher heights,” said
But the
Plus, stocks already look too expensive to many professional investors after their prices surged so much.
Some of the market’s sharpest action was among companies agreeing to buy one another.
Metsera’s stock jumped 61.9%, and Pfizer’s rose 3.1%.
ODP, which runs
In stock markets abroad, indexes were mixed across
Japan’s
In the bond market,
___
AP Business Writers



Mortgage Leader Discusses Impact of Fed Rate Cut on Home Lending
How NC’s Berger broke from Tillis on Medicaid after a call from a Trump ally
Advisor News
- Addressing the ‘menopause tax:’ A guide for advisors with female clients
- Alternative investments in 401(k)s: What advisors must know
- The modern advisor: Merging income, insurance, and investments
- Financial shocks, caregiving gaps and inflation pressures persist
- Americans unprepared for increased longevity
More Advisor NewsAnnuity News
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
- Aspida Life and WealthVest Offer a Powerful New Guaranteed Income Product with the WealthLock® Income Builder
- Lack of digital tools drives wedge between insurers, advisors
- LIMRA: Annuity sales notch 10th consecutive $100B+ quarter
- AIG to sell remaining shares in Corebridge Financial
More Annuity NewsHealth/Employee Benefits News
- We can't afford to let Democrats lead health care 'reform' | Opinion
- Expanding Medicaid coverage lowered death rates for young adults with kidney failure
- GLP-1s: Rewriting the relationship between pharmacy benefits and stop-loss
- Studies from Denise Wolff et al Have Provided New Data on Atopic Dermatitis (AMCP Market Insights: Beyond skin deep on the role of managed care in moderate to severe atopic dermatitis): Skin Diseases and Conditions – Atopic Dermatitis
- New Clinical Trials and Studies Findings from RAND Corporation Described (Benefit design and consumer information: results from a randomized trial): Clinical Research – Clinical Trials and Studies
More Health/Employee Benefits NewsLife Insurance News
- 3 ways AI can help close the gap for women’s insurance coverage
- Best’s Market Segment Report: AM Best Revises Outlook on Italy’s Life Insurance Segment to Stable From Negative
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
- Dan Scholz to receive NAIFA’s Terry Headley Lifetime Defender Award
- Best’s Special Report: US Property/Casualty and Health Insurers Exceed Cost of Capital; Life Insurers Narrowly Miss
More Life Insurance News